Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(NY:
ANRO
)
14.18
+0.05 (+0.35%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
22,746
Open
13.94
Bid (Size)
13.30 (3)
Ask (Size)
15.91 (1)
Prev. Close
14.13
Today's Range
13.94 - 14.18
52wk Range
12.78 - 24.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In Neuropsychiatry Landscape
April 23, 2024
Alto Neuroscience reported positive results for its novel PDE4 inhibitor in a Phase 1 study for cognitive impairment associated with schizophrenia.
Via
Benzinga
Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
April 23, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Performance
YTD
-31.50%
-31.50%
1 Month
-7.62%
-7.62%
3 Month
-31.50%
-31.50%
6 Month
-31.50%
-31.50%
1 Year
-31.50%
-31.50%
More News
Read More
Alto Neuroscience Announces Initiation of Phase 2 Study of ALTO-203 in Patients with Major Depressive Disorder
April 03, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
March 21, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors
March 11, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience to Participate in Upcoming Investor Conferences
March 07, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference
February 27, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 06, 2024
From
Alto Neuroscience, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 05, 2024
Via
InvestorPlace
Maker Of Wilson Tennis Rackets Raises $1.37 Billion In Discounted IPO
February 04, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.